|Day's Range||0.15 - 0.15|
|52 Week Range||0.09 - 0.28|
|PE Ratio (TTM)||-1.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Paratek, Cyclacel and Benitec stocks led a biotech surge on Tuesday, rising on strong trial results.
The company announced preclinical data supporting its gene replacement therapy in a rare muscle disease.
Benitec Biopharma saw its shares more than double on Tuesday after the company gave a business update on its ddRNAi technology for the development of therapeutics for the treatment of ocular diseases.